Accomplishments, Collaborative Projects and Future Initiatives in Breast Cancer Genetic Predisposition PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Accomplishments, Collaborative Projects and Future Initiatives in Breast Cancer Genetic Predisposition PDF full book. Access full book title Accomplishments, Collaborative Projects and Future Initiatives in Breast Cancer Genetic Predisposition by Paolo Peterlongo. Download full books in PDF and EPUB format.
Author: Paolo Peterlongo
Publisher: Frontiers Media SA
ISBN: 288963132X
Category :
Languages : en
Pages : 141
Get Book Here
Book Description
In this eBook, we described the accomplishments, collaborative projects and future initiatives in the field of breast cancer genetic predisposition. More specifically, the articles included focused on aspects such as mutation screening in unexplored populations, identification and characterization of novel predisposing genes and mutations, and population screening.
Author: Paolo Peterlongo
Publisher: Frontiers Media SA
ISBN: 288963132X
Category :
Languages : en
Pages : 141
Get Book Here
Book Description
In this eBook, we described the accomplishments, collaborative projects and future initiatives in the field of breast cancer genetic predisposition. More specifically, the articles included focused on aspects such as mutation screening in unexplored populations, identification and characterization of novel predisposing genes and mutations, and population screening.
Author:
Publisher:
ISBN:
Category :
Languages : en
Pages : 1822
Get Book Here
Book Description
Author: United States. Congress. House. Committee on Appropriations. Subcommittee on the Departments of Labor, Health and Human Services, Education, and Related Agencies
Publisher:
ISBN:
Category : Political Science
Languages : en
Pages : 1830
Get Book Here
Book Description
Author: World Health Organization
Publisher:
ISBN: 9789241565462
Category : Medical instruments and apparatus
Languages : en
Pages : 246
Get Book Here
Book Description
This is the model list and clearing house of appropriate, basic, and priority medical devices based on the list of clinical interventions selected from clinical guidelines on prevention, screening, diagnosis, treatment, palliative care, monitoring, and end of life care. This publication addresses medical devices that can be used for the management of cancer and specifically describes medical devices for six types of cancer: breast, cervical, colorectal, leukemia, lung, and prostate. This book is intended for ministries of health, public health planners, health technology managers, disease management, researchers, policy makers, funding, and procurement agencies and support and advocacy groups for cancer patients.
Author: United States. Congress. House. Committee on Appropriations. Subcommittee on the Departments of Labor, Health and Human Services, Education, and Related Agencies
Publisher:
ISBN:
Category : United States
Languages : en
Pages : 1734
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category : Cancer
Languages : en
Pages : 1032
Get Book Here
Book Description
Author: Bruce A. Chabner
Publisher: Lippincott Williams & Wilkins
ISBN: 1451148208
Category : Medical
Languages : en
Pages : 836
Get Book Here
Book Description
Updated to include the newest drugs and those currently in development, this Fifth Edition is a comprehensive reference on the preclinical and clinical pharmacology of anticancer agents. Organized by drug class, the book provides the latest information on all drugs and biological agents—their mechanisms of action, interactions with other agents, toxicities, side effects, and mechanisms of resistance. The authors explain the rationale for use of drugs in specific schedules and combinations and offer guidelines for dose adjustment in particular situations. This edition's introduction includes timely information on general strategies for drug usage, the science of drug discovery and development, economic and regulatory aspects of cancer drug development, and principles of pharmacokinetics. Eight new chapters have been added and more than twenty have been significantly revised. A companion website includes the fully searchable text and an image bank.
Author:
Publisher:
ISBN:
Category : Environmental health
Languages : en
Pages : 524
Get Book Here
Book Description
Author: Israel Gomy
Publisher: BoD – Books on Demand
ISBN: 183968142X
Category : Medical
Languages : en
Pages : 106
Get Book Here
Book Description
The field of medical genetics and genomics has been constantly revolutionized by new breakthroughs, which bring more knowledge into the etiology and help improve the health care of individuals with either rare or common diseases. Nevertheless, as technologies evolve, novel challenges emerge, both technically and ethically, so they must be prudentially addressed. Among the myriad applications of genomics in medicine, this book depicts a glimpse of the advances achieved that have been leading us to the personalized/precision medicine era.
Author: Ari VanderWalde
Publisher:
ISBN: 9783036528205
Category :
Languages : en
Pages : 174
Get Book Here
Book Description
Nowhere is the explosion in comprehensive genomic testing more evident than in oncology. Multiple consensus guidelines now recommend molecular testing as the standard of care for most metastatic tumors. To aid in the advancement of this rapidly changing field, we intend this Special Issue of JPM to focus on technical developments in the genomic profiling of cancer, detail promising somatic alterations that either are, or have a high likelihood of being, relevant in the near future, and to address issues related to the pricing and value of these tests.The last few years have seen the cost of molecular testing decrease by orders of magnitude. In 2018, we saw the first “site-agnostic” drug approvals in cancer (for microsatellite unstable cancer (PD-1 inhibitors) and NTRK-fusions (TRK inhibitors)). Research on targetable mutations, determination of genetic “signatures” that can use multiple individual genes/pathways, development of targeted therapy, and insight into the value of new technology remains at the cutting edge of research in this field. We are soliciting papers that present new technologies to assess predictive biomarkers in cancer, original research (pre-clinical or clinical) that demonstrates promise for particular targeted therapies in cancer, and articles that explore the clinical and financial impacts of this paradigmatic shift in cancer diagnostics and treatment.
